Repositorio Dspace

iPSC-based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation

Mostrar el registro sencillo del ítem

dc.contributor.author Tristan-Noguero, Alba
dc.contributor.author Fernández-Carasa, Irene
dc.contributor.author Calatayud, Carles
dc.contributor.author Bermejo-Casadesus, Cristina
dc.contributor.author Pons-Espinal, Meritxell
dc.contributor.author Baldeschi, Arianna-Colini
dc.contributor.author Campa, Leticia
dc.contributor.author Artigas, Francesc
dc.contributor.author Bortolozzi, Analia
dc.contributor.author Domingo-Jiménez, Rosario
dc.contributor.author Ibáñez, Salvador
dc.contributor.author Pineda, Mercè
dc.contributor.author Artuch, Rafael
dc.contributor.author Raya, Ángel
dc.contributor.author García-Cazorla, Ángels
dc.contributor.author Consiglio, Antonella
dc.date.accessioned 2025-11-20T12:48:32Z
dc.date.available 2025-11-20T12:48:32Z
dc.date.issued 2023-03
dc.identifier.citation Tristán-Noguero A, Fernández-Carasa I, Calatayud C, Bermejo-Casadesús C, Pons-Espinal M, Colini Baldeschi A, et al. iPSC -based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation. EMBO Mol Med. 8 de marzo de 2023;15(3):e15847.
dc.identifier.issn 1757-4676
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/21745
dc.description.abstract Tyrosine hydroxylase deficiency (THD) is a rare genetic disorder leading to dopaminergic depletion and early-onset Parkinsonism. Affected children present with either a severe form that does not respond to L-Dopa treatment (THD-B) or a milder L-Dopa responsive form (THD-A). We generated induced pluripotent stem cells (iPSCs) from THD patients that were differentiated into dopaminergic neurons (DAn) and compared with control-DAn from healthy individuals and gene-corrected isogenic controls. Consistent with patients, THD iPSC-DAn displayed lower levels of DA metabolites and reduced TH expression, when compared to controls. Moreover, THD iPSC-DAn showed abnormal morphology, including reduced total neurite length and neurite arborization defects, which were not evident in DAn differentiated from control-iPSC. Treatment of THD-iPSC-DAn with L-Dopa rescued the neuronal defects and disease phenotype only in THDA-DAn. Interestingly, L-Dopa treatment at the stage of neuronal precursors could prevent the alterations in THDB-iPSC-DAn, thus suggesting the existence of a critical developmental window in THD. Our iPSC-based model recapitulates THD disease phenotypes and response to treatment, representing a promising tool for investigating pathogenic mechanisms, drug screening, and personalized management.
dc.language.iso eng
dc.publisher SPRINGERNATURE
dc.rights Atribución-NoComercial-SinDerivadas 3.0 España
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/3.0/es/ *
dc.subject.mesh Levodopa/therapeutic use/metabolism
dc.subject.mesh Dopaminergic Neurons/metabolism
dc.subject.mesh Dystonic Disorders/congenital
dc.subject.mesh Phenotype
dc.subject.mesh Humans
dc.subject.mesh Induced Pluripotent Stem Cells/metabolism
dc.title iPSC-based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 36740977
dc.relation.publisherversion https://www.embopress.org/doi/10.15252/emmm.202215847
dc.identifier.doi 10.15252/emmm.202215847
dc.journal.title Embo Molecular Medicine
dc.identifier.essn 1757-4684


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-SinDerivadas 3.0 España Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 3.0 España

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta